Company: HCTI
Filing Date: 2025-10-02
Form Type: PRE 14C
Source: 0001213900-25-095494
Chunk: 3

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-02
Form: PRE 14C
Chunk 3
---
 19, 2025. Our board of directors is not soliciting your consent or your
proxy in connection with this action and neither consents nor proxies are being requested from stockholders.

No further action of shareholders is required
in connection with the approval of the issuance of the Acquisition Shares.

This Information Statement is furnished solely
for the purpose of informing our shareholders, in the manner required by the Exchange Act and Section 228(e) of the GCL, of
the action taken by written consent of the Majority Stockholder. Pursuant to Rule 14c-2 under the Exchange Act, the action
approved by written consent may not be taken until 20 days after the date that we transmit this Information Statement to our shareholders.

We will commence mailing the notice to holders
of common stock on or about October [*], 2025.

Approval of the Transaction

As of the Record Date, there were issued
and outstanding [*] shares of the Company’s common stock. The Majority Stockholder is Suresh Venkatachari, who holds 20,000 shares
of Series A Super Voting Preferred Stock, which entitles the holder to 1,000 votes per share, representing approximately 81.82% of the
voting power of all shares of voting stock of the Company as of the Record Date:

<div align='center'>2

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth information with
respect to the beneficial ownership of our common stock and our Series A Super Voting Preferred Stock, our only outstanding classes of
capital stock having the right to vote on this matter, known by us as of the Record Date, by:

| ● | each person or entity known by us to be the beneficial owner of more 
 than 5% of our common stock;                                         |
| ● | each of our directors;                                               |
| ● | each of our executive officers; and                                  |
| ● | all of our directors and executive officers as a group.              |

Beneficial ownership of the voting stock is determined
in accordance with the rules of the United States Securities and Exchange Commission (the “SEC”) and includes any
shares of Company voting stock over which a person exercises sole or shared voting or investment power, or of which a person has a right
to acquire ownership at any time within 60 days of September 19, 2025. Except as otherwise indicated, we believe that the persons named
in this table have sole